Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-derived exosomes for diabetic foot ulcers
IRCT20240317061316N1Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jun 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, double-blind trial of mesenchymal stem cell exosomes in diabetic foot ulcer (DFU) (4 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Gender of patients, Age of patients and 10 more. Started Jun 2024; status: completed.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20240317061316N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240317061316N1.